Beacon Capital Management LLC (Tennessee)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Beacon Capital Management LLC (Tennessee)'s PFE Position: Q2 2026 in Review
Beacon Capital Management LLC (Tennessee) reduced its Pfizer (PFE) stake by 18% in Q2 2026, selling an estimated $49.3K and leaving 8,742 shares worth $211K. The position accounts for 0.03% of the portfolio, ranked #161.
Beacon Capital Management LLC (Tennessee) first reported a position in PFE in Q1 2022 and has held it in 18 quarters since. The position peaked at $572K in Q4 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Beacon Capital Management LLC (Tennessee) held 8,742 shares of Pfizer worth $211K as of Q2 2026.
- Beacon Capital Management LLC (Tennessee) sold 1,886 Pfizer shares in Q2 2026, an estimated $49.3K.
- Pfizer made up 0.03% of Beacon Capital Management LLC (Tennessee)'s portfolio in Q2 2026, its #161 holding.
- Beacon Capital Management LLC (Tennessee) first reported a position in Pfizer in Q1 2022 and has held it in 18 quarters since.
- Beacon Capital Management LLC (Tennessee)'s Pfizer position peaked at $572K in Q4 2022.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q2 2026, filed 29 Jul 2026.